National Comprehensive Cancer Network



About NCCN

Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenstrm's Macroglobulinemia Panel - Disclosures as of 8/13/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Melissa Alsina, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Ortho Biotech Products, L.P.

None

None

None

Kenneth C. Anderson, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

acetylon;
acetylon;
oncopep;
oncopep

None

William Bensinger, MD

None

Celgene Corporation;
Genzyme Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

J. Sybil Biermann, MD

None

None

None

None

None

Adam D. Cohen, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Celgene Corporation

None

None

None

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

None

None

None

Benjamin Djulbegovic, MD, PhD

None

None

None

None

None

Edward A. Faber, Jr., DO, MS

None

sanofi-aventis U.S.

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Cristina Gasparetto, MD

None

Celgene Corporation;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Francisco Hernandez-Ilizaliturri, MD

None

Amgen Inc.;
Celgene Corporation

None

None

None

Carol Ann Huff, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

None

Adetola Kassim, MD, MS

None

Celgene Corporation

None

None

None

Amrita Y. Krishnan, MD, FACP

None

Celgene Corporation;
Genentech, Inc.;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.

None

Celgene Corporation

None

Rashmi Kumar, PhD

None

None

None

None

None

Michaela Liedtke, MD

None

Celgene Corporation

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Ruby Meredith, MD, PhD

None

None

None

None

None

Noopur Raje, MD

None

Amgen Inc.;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

None

Dorothy Shead, MS

None

None

None

None

None

Seema Singhal, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

None

George Somlo, MD

None

Celgene Corporation;
Eisai Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
Abraxane;
Roche Laboratories, Inc.

None

None

None

Keith Stockerl-Goldstein, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

None

Steven P. Treon, MD, PhD

None

None

None

None

None

Donna M. Weber, MD

None

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
proteolix

None

None

None

Joachim Yahalom, MD

None

None

None

None

None